Edition:
India

People: Quest Diagnostics Inc (DGX.N)

DGX.N on New York Stock Exchange

127.06USD
1:33am IST
Change (% chg)

$-1.04 (-0.81%)
Prev Close
$128.10
Open
$128.43
Day's High
$128.43
Day's Low
$126.17
Volume
181,347
Avg. Vol
410,984
52-wk High
$131.60
52-wk Low
$73.03

Manner, Carrie 

Ms. Carrie Eglinton Manner serves as Senior Vice President - Advanced Diagnostics of the Company. Ms. Eglinton Manner joined the Company in January 2017. She is responsible for the Company's advanced testing activities, including overseeing the development of clinical franchise solutions in the areas of neurology, oncology, pathology and women's health, as well as the Company's global business and pharmaceutical/diagnostic development services. Previously, Ms. Eglinton Manner spent over 20 years in various leadership roles in healthcare businesses at General Electric. From 2015 to 2016, she served as President and CEO of the Detection and Guidance Solutions business, delivering advanced x-ray technologies spanning the continuum of healthcare. From 2013 to 2015, Ms. Eglinton Manner served as President and CEO of OEC Surgical Mobile C-arm systems. She was President and CEO of General Electric's diagnostic pathology laboratory services business from 2012 to 2013, and President of the Maternal Infant Care Business from 2009 to 2012.

Basic Compensation

Total Annual Compensation, USD 929,099
Restricted Stock Award, USD 1,001,320
Long-Term Incentive Plans, USD --
All Other, USD 747,138
Fiscal Year Total, USD 2,677,560

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Stephen Rusckowski

10,118,500

Mark Guinan

3,316,000

James Davis

3,122,920

Michael Prevoznik

2,090,390

Catherine Doherty

2,319,220

Carrie Manner

2,677,560
As Of  31 Dec 2019